Monoclonal Antibody Index. Cancer.

MONOCLONAL ANTIBODY INDEX. Volume 1: Cancer -- 11th edition.
All rights reserved. Copyright by Gallart Biotech SL, 2008.

BIBLIOGRAPHY (Ordered by OUR ID).

OUR ID REFERENCES OF PRODUCTION AND CHARACTERISTICS (antibody/antigen) REFERENCES OF DIAGNOSTIC AND THERAPEUTIC USE

1351 Cancer Biother Radiopharm, 14, 139, 99 -- Mol Immunol, 36, 789, 99 -- Cancer Immunol Immunother, 43, 26, 96 -- Hum Antibodies Hybridomas, 6, 57, 95 (chimeric) -- Cancer Res, 47, 830, 87 -- Hybridoma, 5, 265, 86 -- US Patent 6783936 (peptide epitopes) -- US Patent 6696276 -- US Patent 6403096 -- US Patent 6274343 -- US Patent 6217871 (epitopes) -- US Patent 5194594 -- US Patent 5053394 (American Cyanamid Co., US) -- US Patent 4724213 -- PCT Patent Application 00/24777 Leuk Lymphoma, 48, 944, 07 (chimeric) -- J Nucl Med, 48, 1338, 07 -- Cancer Biother Radiopharm, 22, 342, 07 -- Clin Cancer Res, 13, 5621s, 07 -- Cancer Immunol Immunother, 55, 1451, 06 -- Clin Cancer Res, 11, 7075s, 05 -- Cancer Biother Radiopharm, 19, 545, 04 -- J Natl Cancer Inst, 95, 741, 03 -- Blood, 101, 3641, 03 -- Cancer Biother Radiopharm, 18, 231, 03 -- J Nucl Med, 44, 1322, 03 -- Cancer Immunol Immunother, 52, 309, 03 -- Cancer Immunol Immunother, 52, 309, 03 -- Br J Cancer, 85, 463, 01 -- Cancer Biother Radiopharm, 16, 213, 01 -- Clin Lymphoma, 1, 112, 00 -- J Leukoc Biol, 68, 662, 00 -- Anticancer Res, 20, 3647, 00 -- Cancer Radiother Biopharm, 14, 167, 99 -- Clin Cancer Res, 5, 533, 99 -- Br J Cancer, 80, 331, 99 -- J Nucl Med, 40, 1317 and 2014, 99 -- J Nucl Med, 39, 667, 98 -- Anticancer Res, 18, 2779, 98 -- Clin Cancer Res, 3, 1253, 97 -- Clin Cancer Res, 3, 71, 97 -- Cancer, 80, suppl 12, 2706, 97 -- Cancer Biother Biopharm, 11, 203, 96 -- Cancer Res, 56, 4998, 96 -- Blood, 87, 5171, 96 -- Blood, 87, 3803, 96 -- Int J Biol Markers, 10, 67, 95 -- J Immunother Emph Tumor Immunol, 18, 221, 95 -- Cancer, 73, 1425, 94 -- Cancer Biother, 8, 3, 93 -- J Nucl Med, 31, 473, 90 -- J Nucl Med, 31, 1059, 90 -- Cancer Res, 50, 2991, 90 -- Hematol Oncol, 7, 155, 89 -- J Nucl Med, 29, 217, 88 -- Int J Cancer, suppl 3, 96, 88 -- Int J Biol Markers, 2, 49, 87 -- J Nucl Med, 27, 1243, 86

BIBLIOGRAPHY (Ordered by OUR ID).
OUR ID	REFERENCES OF PRODUCTION AND CHARACTERISTICS (antibody/antigen)	REFERENCES OF DIAGNOSTIC AND THERAPEUTIC USE
1351	Cancer Biother Radiopharm, 14, 139, 99 -- Mol Immunol, 36, 789, 99 -- Cancer Immunol Immunother, 43, 26, 96 -- Hum Antibodies Hybridomas, 6, 57, 95 (chimeric) -- Cancer Res, 47, 830, 87 -- Hybridoma, 5, 265, 86 -- US Patent 6783936 (peptide epitopes) -- US Patent 6696276 -- US Patent 6403096 -- US Patent 6274343 -- US Patent 6217871 (epitopes) -- US Patent 5194594 -- US Patent 5053394 (American Cyanamid Co., US) -- US Patent 4724213 -- PCT Patent Application 00/24777	Leuk Lymphoma, 48, 944, 07 (chimeric) -- J Nucl Med, 48, 1338, 07 -- Cancer Biother Radiopharm, 22, 342, 07 -- Clin Cancer Res, 13, 5621s, 07 -- Cancer Immunol Immunother, 55, 1451, 06 -- Clin Cancer Res, 11, 7075s, 05 -- Cancer Biother Radiopharm, 19, 545, 04 -- J Natl Cancer Inst, 95, 741, 03 -- Blood, 101, 3641, 03 -- Cancer Biother Radiopharm, 18, 231, 03 -- J Nucl Med, 44, 1322, 03 -- Cancer Immunol Immunother, 52, 309, 03 -- Cancer Immunol Immunother, 52, 309, 03 -- Br J Cancer, 85, 463, 01 -- Cancer Biother Radiopharm, 16, 213, 01 -- Clin Lymphoma, 1, 112, 00 -- J Leukoc Biol, 68, 662, 00 -- Anticancer Res, 20, 3647, 00 -- Cancer Radiother Biopharm, 14, 167, 99 -- Clin Cancer Res, 5, 533, 99 -- Br J Cancer, 80, 331, 99 -- J Nucl Med, 40, 1317 and 2014, 99 -- J Nucl Med, 39, 667, 98 -- Anticancer Res, 18, 2779, 98 -- Clin Cancer Res, 3, 1253, 97 -- Clin Cancer Res, 3, 71, 97 -- Cancer, 80, suppl 12, 2706, 97 -- Cancer Biother Biopharm, 11, 203, 96 -- Cancer Res, 56, 4998, 96 -- Blood, 87, 5171, 96 -- Blood, 87, 3803, 96 -- Int J Biol Markers, 10, 67, 95 -- J Immunother Emph Tumor Immunol, 18, 221, 95 -- Cancer, 73, 1425, 94 -- Cancer Biother, 8, 3, 93 -- J Nucl Med, 31, 473, 90 -- J Nucl Med, 31, 1059, 90 -- Cancer Res, 50, 2991, 90 -- Hematol Oncol, 7, 155, 89 -- J Nucl Med, 29, 217, 88 -- Int J Cancer, suppl 3, 96, 88 -- Int J Biol Markers, 2, 49, 87 -- J Nucl Med, 27, 1243, 86

DATA TABLE HOME